The influence of curcumin on the action of etoposide in a rat acute myeloid leukemia cell line.
暂无分享,去创建一个
[1] R. Cordell,et al. Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage , 2012, Carcinogenesis.
[2] E. Saleh,et al. Antagonism between curcumin and the topoisomerase II inhibitor etoposide , 2012, Cancer biology & therapy.
[3] S. Nair,et al. Potentiation of Etoposide and Temozolomide Cytotoxicity by Curcumin and Turmeric Force in Brain Tumor Cell Lines , 2012, Journal of complementary & integrative medicine.
[4] E. Sreekumar,et al. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer , 2011, Oncogene.
[5] Yun-Wei Lin,et al. Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1) , 2011, Molecular Pharmacology.
[6] Jin-jian Lu,et al. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells , 2011, Molecular and Cellular Biochemistry.
[7] Bharat B. Aggarwal,et al. Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs , 2010, Nutrition and cancer.
[8] Lagadinou D. Eleni,et al. Challenges in Treating Older Patients with Acute Myeloid Leukemia , 2010, Journal of oncology.
[9] G. Nowak,et al. Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[10] Jinshui Fan,et al. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. , 2008, Cancer letters.
[11] V. Morsch,et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. , 2008, Clinical biochemistry.
[12] Xiao-Ming Yin,et al. Cyanidin-3-rutinoside, a Natural Polyphenol Antioxidant, Selectively Kills Leukemic Cells by Induction of Oxidative Stress* , 2007, Journal of Biological Chemistry.
[13] L. Eissa,et al. Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients , 2007, The Journal of pharmacy and pharmacology.
[14] J. Meyers,et al. Preclinical assessment of curcumin as a potential therapy for B‐CLL , 2007, American journal of hematology.
[15] J. Bujnicki,et al. Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells , 2006, Molecular Cancer Therapeutics.
[16] T. Yokochi,et al. Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2'-deoxyguanosine in DNA and induction of apoptotic cell death. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.
[17] A. Khar,et al. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. , 2004, Molecular cancer therapeutics.
[18] D. Dickinson,et al. Green Tea Polyphenol Causes Differential Oxidative Environments in Tumor versus Normal Epithelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.
[19] Chao-yuan Huang,et al. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF‐κB activation , 2002, The Prostate.
[20] Y. Tyurina,et al. Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach. , 1999, Molecular pharmacology.
[21] H. Ahsan,et al. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. , 1999, Chemico-biological interactions.
[22] W. Kaufmann. Human Topoisomerase II Function, Tyrosine Phosphorylation and Cell Cycle Checkpoints , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[23] S. Joel,et al. The clinical pharmacology of etoposide: an update. , 1996, Cancer treatment reviews.
[24] N. Osheroff,et al. When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. , 1993, Chemical research in toxicology.
[25] A. Hagenbeek,et al. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)). , 1990, Leukemia.
[26] Roberta Riccioni,et al. Deregulation of apoptosis in acute myeloid leukemia. , 2007, Haematologica.
[27] Bob Löwenberg,et al. Acute myeloid leukemia and acute promyelocytic leukemia. , 2003, Hematology. American Society of Hematology. Education Program.
[28] B. Aggarwal,et al. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. , 2002, Carcinogenesis.
[29] R. Tice,et al. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. , 1991, Advances in experimental medicine and biology.
[30] S. Das,et al. Sister chromatid exchange and chromosome aberrations induced by curcumin and tartrazine on mammalian cells in vivo. , 1990, Cytobios.
[31] Paul Talalay,et al. Analysis of combined drug effects: a new look at a very old problem , 1983 .